Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-21

Clinical Trial Update: NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB [Phase 3]

View source ↗

Summary

This Phase 3 trial compares neoadjuvant chemotherapy followed by radical hysterectomy versus primary chemoradiation for FIGO stage IB2/IIB cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Cervical Cancer | Phase 3 | Status: UNKNOWN